<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35581326</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology.</ArticleTitle><Pagination><StartPage>8140</StartPage><MedlinePgn>8140</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8140</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-12191-8</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no cure or effective treatment in which TAR DNA Binding Protein of 43&#xa0;kDa (TDP-43) abnormally accumulates into misfolded protein aggregates in affected neurons. It is widely accepted that protein misfolding and aggregation promotes proteotoxic stress. The molecular chaperones are a primary line of defense against proteotoxic stress, and there has been long-standing interest in understanding the relationship between chaperones and aggregated protein in ALS. Of particular interest are the heat shock protein of 70&#xa0;kDa (Hsp70) family of chaperones. However, defining which of the 13 human Hsp70 isoforms is critical for ALS has presented many challenges. To gain insight into the specific Hsp70 that modulates TDP-43, we investigated the relationship between TDP-43 and the Hsp70s using proximity-dependent biotin identification (BioID) and discovered several Hsp70 isoforms associated with TDP-43 in the nucleus, raising the possibility of an interaction with native TDP-43. We further found that HspA5 bound specifically to the RNA-binding domain of TDP-43 using recombinantly expressed proteins. Moreover, in a Drosophila strain that mimics ALS upon TDP-43 expression,&#xa0;the mRNA levels of the HspA5 homologue (Hsc70.3) were significantly increased. Similarly&#xa0;we observed upregulation&#xa0;of HspA5 in prefrontal cortex neurons from human ALS patients. Finally, overexpression of HspA5 in Drosophila rescued TDP-43-induced toxicity, suggesting that upregulation of HspA5 may have a compensatory role in ALS pathobiology.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fran&#xe7;ois-Moutal</LastName><ForeName>Liberty</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, 85724, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovation in Brain Science, Tucson, AZ, 85721, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>David Donald</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, 85724, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovation in Brain Science, Tucson, AZ, 85721, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrose</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ, 85724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zerio</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Pharmacology and Toxicology, School of Pharmacy, University of Arizona, Tucson, AZ, 85724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Sanchez</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Pathobiology, NYU, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dissanayake</LastName><ForeName>Kumara</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Danielle G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Enabling Technologies Group, Sanford Research, Sioux Falls, SD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlson</LastName><ForeName>Jacob M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, 85724, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovation in Brain Science, Tucson, AZ, 85721, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbieri</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moutal</LastName><ForeName>Aubin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, 85724, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovation in Brain Science, Tucson, AZ, 85721, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roux</LastName><ForeName>Kyle J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Enabling Technologies Group, Sanford Research, Sioux Falls, SD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorter</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, 85724, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovation in Brain Science, Tucson, AZ, 85721, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barmada</LastName><ForeName>Sami J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGurk</LastName><ForeName>Leeanne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>May</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, 85724, USA. mk8363@nyu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovation in Brain Science, Tucson, AZ, 85721, USA. mk8363@nyu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Pathobiology, NYU, New York, NY, USA. mk8363@nyu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Pathobiology, College of Dentistry, NYU, 433 1st Ave, New York, NY, 10010, USA. mk8363@nyu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG053760</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS097542</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35GM126949</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM103620</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM126949</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072931</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG065854</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS097542</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS113943</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000091342">Endoplasmic Reticulum Chaperone BiP</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018840">HSP70 Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006360">Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091342" MajorTopicYN="N">Endoplasmic Reticulum Chaperone BiP</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018840" MajorTopicYN="N">HSP70 Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006360" MajorTopicYN="N">Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Sanford Research has licensed BioID reagents to BioFront Technologies. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35581326</ArticleId><ArticleId IdType="pmc">PMC9114370</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-12191-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-12191-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE. Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 2009;78:959&#x2013;991. doi: 10.1146/annurev.biochem.052308.114844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.052308.114844</ArticleId><ArticleId IdType="pubmed">19298183</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Neumann M. Molecular neuropathology of frontotemporal dementia: Insights into disease mechanisms from postmortem studies. J. Neurochem. 2016;138:54&#x2013;70. doi: 10.1111/jnc.13588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13588</ArticleId><ArticleId IdType="pubmed">27306735</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ, Lee VMY. Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem. 2009;284:8516&#x2013;8524. doi: 10.1074/jbc.M809462200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809462200</ArticleId><ArticleId IdType="pmc">PMC2659210</ArticleId><ArticleId IdType="pubmed">19164285</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, Forman MS, Troost D, Kretzschmar HA, Trojanowski JQ, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning BA, Walker AK. The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD. Front. Neurosci. 2019;13:335. doi: 10.3389/fnins.2019.00335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW. TDP-43 Immunoreactivity in Hippocampal Sclerosis and Alzheimer&#x2019;s Disease. Ann. Neurol. 2007;61:435&#x2013;445. doi: 10.1002/ana.21154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21154</ArticleId><ArticleId IdType="pmc">PMC2677204</ArticleId><ArticleId IdType="pubmed">17469117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, et al. Limbic-Predominant Age-Related TDP-43 Encephalopathy (LATE): Consensus Working Group Report. Brain. 2019;142:1503&#x2013;1527. doi: 10.1093/brain/awz099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz099</ArticleId><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, et al. Astrocytic TDP-43 pathology in Alexander disease. J. Neurosci. 2014 doi: 10.1523/JNEUROSCI.0248-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0248-14.2014</ArticleId><ArticleId IdType="pmc">PMC4012304</ArticleId><ArticleId IdType="pubmed">24806671</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Vance C, Nishimura AL, Lee YB, Chen HJ, Urwin H, Sardone V, Mitchell JC, Rogelj B, Rubinsztein DC, et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 2014;127:1263&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R, Fani G, Bigi A, Chiti F, Cecchi C. Partial failure of proteostasis systems counteracting TDP-43 aggregates in neurodegenerative diseases. Int. J. Mol. Sci. 2019;20:3685. doi: 10.3390/ijms20153685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20153685</ArticleId><ArticleId IdType="pmc">PMC6695586</ArticleId><ArticleId IdType="pubmed">31357627</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Coyne AN, Pei F, Vaughan S, Chaung M, Zarnescu DC, Buchan JR. Endocytosis regulates TDP-43 toxicity and turnover. Nat. Commun. 2017;8:1&#x2013;14. doi: 10.1038/s41467-016-0009-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-016-0009-6</ArticleId><ArticleId IdType="pmc">PMC5727062</ArticleId><ArticleId IdType="pubmed">29233983</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, Li Y, Chang WH, Hung ST, Hendricks E, Linares GR, Wang Y, Son EY, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C, Deisel J, Aufschnaiter A, Ambros S, Tereshchenko M, Verheijen BM, B&#xfc;ttner S, Braun RJ. Endolysosomal pathway activity protects cells from neurotoxic TDP-43. Microbial Cell. 2018;5:212&#x2013;214. doi: 10.15698/mic2018.04.627.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/mic2018.04.627</ArticleId><ArticleId IdType="pmc">PMC5878689</ArticleId><ArticleId IdType="pubmed">29611555</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois-Moutal L, Perez-Miller S, Scott DD, Miranda VG, Mollasalehi N, Khanna M. Structural insights into TDP-43 and effects of post-translational modifications. Front. Mol. Neurosci. 2019 doi: 10.3389/fnmol.2019.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD. ALS genetics: Gains, losses, and implications for future therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener. 2020;15:1&#x2013;16. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter CM, Truman AW, Truttmann MC. Post-translational modifications of Hsp70 family proteins: Expanding the chaperone code. J. Biol. Chem. 2020;295:10689&#x2013;10705. doi: 10.1074/jbc.RA119.010999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.010999</ArticleId><ArticleId IdType="pmc">PMC7397107</ArticleId><ArticleId IdType="pubmed">32518165</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerico EM, Pozhidaeva AK, Jansen RM, &#xd6;zden C, Tilitsky JM, Gierasch LM. Selective promiscuity in the binding of E. Coli Hsp70 to an unfolded protein. Proc. Natl. Acad. Sci. USA. 2021;118:e2016962118. doi: 10.1073/pnas.2016962118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2016962118</ArticleId><ArticleId IdType="pmc">PMC8521663</ArticleId><ArticleId IdType="pubmed">34625496</ArticleId></ArticleIdList></Reference><Reference><Citation>Radons J. The human HSP70 family of chaperones: Where Do We Stand? Cell Stress Chaperones. 2016;21:379&#x2013;404. doi: 10.1007/s12192-016-0676-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-016-0676-6</ArticleId><ArticleId IdType="pmc">PMC4837186</ArticleId><ArticleId IdType="pubmed">26865365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrose AJ, Chapman E. Function, therapeutic potential, and inhibition of Hsp70 chaperones. J. Med. Chem. 2021;64:7060&#x2013;7082. doi: 10.1021/acs.jmedchem.0c02091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.0c02091</ArticleId><ArticleId IdType="pubmed">34009983</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerico EM, Tilitsky JM, Meng W, Gierasch LM. How Hsp70 molecular machines interact with their substrates to mediate diverse physiological functions. J. Mol. Biol. 2015;427:1575&#x2013;1588. doi: 10.1016/j.jmb.2015.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.02.004</ArticleId><ArticleId IdType="pmc">PMC4440321</ArticleId><ArticleId IdType="pubmed">25683596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Joo HJ, Kim YH, Ahn S, Chang J, Hwang KB, Lee DH, Lee KJ. Systemic analysis of heat shock response induced by heat shock and a proteasome inhibitor MG132. PLoS ONE. 2011;6:e20252. doi: 10.1371/journal.pone.0020252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020252</ArticleId><ArticleId IdType="pmc">PMC3127947</ArticleId><ArticleId IdType="pubmed">21738571</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenzweig R, Nillegoda NB, Mayer MP, Bukau B. The Hsp70 chaperone network. Nat. Rev. Mol. Cell Biol. 2019;20:665&#x2013;680. doi: 10.1038/s41580-019-0133-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0133-3</ArticleId><ArticleId IdType="pubmed">31253954</ArticleId></ArticleIdList></Reference><Reference><Citation>Inda MC, Joshi S, Wang T, Bolaender A, Gandu S, Koren J, Che AY, Taldone T, Yan P, Sun W, et al. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction. Nat. Commun. 2020;11:1&#x2013;19. doi: 10.1038/s41467-019-14082-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-14082-5</ArticleId><ArticleId IdType="pmc">PMC6965647</ArticleId><ArticleId IdType="pubmed">31949159</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodina A, Wang T, Yan P, Gomes ED, Dunphy MPS, Pillarsetty N, Koren J, Gerecitano JF, Taldone T, Zong H, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538:397&#x2013;401. doi: 10.1038/nature19807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19807</ArticleId><ArticleId IdType="pmc">PMC5283383</ArticleId><ArticleId IdType="pubmed">27706135</ArticleId></ArticleIdList></Reference><Reference><Citation>Batulan Z, Shinder GA, Minotti S, He BP, Doroudchi MM, Nalbantoglu J, Strong MJ, Durham HD. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J. Neurosci. 2003;23:5789&#x2013;5798. doi: 10.1523/JNEUROSCI.23-13-05789.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-13-05789.2003</ArticleId><ArticleId IdType="pmc">PMC6741252</ArticleId><ArticleId IdType="pubmed">12843283</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidwell JL, Houenou LJ, Tytell M. Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration. Cell Stress Chaperones. 2004;9:88&#x2013;98. doi: 10.1379/1466-1268(2004)009&lt;0088:AOHIVI&gt;2.0.CO;2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1379/1466-1268(2004)009&lt;0088:AOHIVI&gt;2.0.CO;2</ArticleId><ArticleId IdType="pmc">PMC1065310</ArticleId><ArticleId IdType="pubmed">15270081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A, Iwasaki N, Kinjo M. Molecular chaperone HSP70 prevents formation of inclusion bodies of the 25-KDa C-terminal fragment of TDP-43 by preventing aggregate accumulation. Cell Stress Chaperones. 2018;23:1177&#x2013;1183. doi: 10.1007/s12192-018-0930-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-018-0930-1</ArticleId><ArticleId IdType="pmc">PMC6237682</ArticleId><ArticleId IdType="pubmed">30099725</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifondorwa DJ, Robinson MB, Hayes CD, Taylor AR, Prevette DM, Oppenheim RW, Caress J, Milligan CE. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2007;27:13173&#x2013;13180. doi: 10.1523/JNEUROSCI.4057-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4057-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673412</ArticleId><ArticleId IdType="pubmed">18045911</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane CAS, Brown IR. Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol. Cell Stress Chaperones. 2016;21:837&#x2013;848. doi: 10.1007/s12192-016-0708-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-016-0708-2</ArticleId><ArticleId IdType="pmc">PMC5003800</ArticleId><ArticleId IdType="pubmed">27273088</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res. 2010;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Udan-Johns M, Bengoechea R, Bell S, Shao J, Diamond MI, True HL, Weihl CC, Baloh RH. Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum. Mol. Genet. 2014;23:157&#x2013;170. doi: 10.1093/hmg/ddt408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt408</ArticleId><ArticleId IdType="pmc">PMC3857952</ArticleId><ArticleId IdType="pubmed">23962724</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Lu S, Gasior K, Singh D, Vazquez-Sanchez S, Tapia O, Toprani D, Beccari MS, Yates JR, Da Cruz S, et al. HSP70 Chaperones RNA-Free TDP-43 into Anisotropic Intranuclear Liquid Spherical Shells. Science. 2020 doi: 10.1126/science.abb4309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb4309</ArticleId><ArticleId IdType="pmc">PMC8286096</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux KJ, Kim DI, Burke B, May DG. BioID: A screen for protein-protein interactions. Curr. Protoc. Protein Sci. 2018;91:19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028010</ArticleId><ArticleId IdType="pubmed">29516480</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamoto N, Matsuoka Y, Kurihara T, Kohno K, Miyagi M, Sakiyama F, Okada Y, Tsunasawa S, Yoneda Y. Antibodies against 70-KD heat shock cognate protein inhibit mediated nuclear import of karyophilic proteins. J. Cell Biol. 1992;119:1047&#x2013;1061. doi: 10.1083/jcb.119.5.1047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.119.5.1047</ArticleId><ArticleId IdType="pmc">PMC2289726</ArticleId><ArticleId IdType="pubmed">1332978</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J, Wei C, He J, Zhang L, Zhou J, Balaji KS, Shen S, Peng J, Sharma A, Fu J. Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19. Int. J. Biol. Sci. 2021;17:897. doi: 10.7150/ijbs.54055.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.54055</ArticleId><ArticleId IdType="pmc">PMC7975696</ArticleId><ArticleId IdType="pubmed">33767597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo Z, Liu F, Yao K, Gao M, Luo Y, Zhang Y. Sp110 enhances macrophage resistance to mycobacterium tuberculosis via inducing endoplasmic reticulum stress and inhibiting anti-apoptotic factors. Oncotarget. 2017;8:64050. doi: 10.18632/oncotarget.19300.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.19300</ArticleId><ArticleId IdType="pmc">PMC5609983</ArticleId><ArticleId IdType="pubmed">28969051</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W, Xu G, Wang C, Sperber SM, Chen Y, Zhou Q, Deng Y, Zhao H. Heat shock 70-KDa protein 5 (Hspa5) is essential for pronephros formation by mediating retinoic acid signaling. J. Biol. Chem. 2015;290:577&#x2013;589. doi: 10.1074/jbc.M114.591628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.591628</ArticleId><ArticleId IdType="pmc">PMC4281759</ArticleId><ArticleId IdType="pubmed">25398881</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Durme J, Maurer-Stroh S, Gallardo R, Wilkinson H, Rousseau F, Schymkowitz J. Accurate prediction of DnaK-peptide binding via homology modelling and experimental data. PLoS Comput. Biol. 2009;5:e100475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717214</ArticleId><ArticleId IdType="pubmed">19696878</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M, Kang J, Lim L, Li Y, Wang L, Song J. ATP is a cryptic binder of TDP-43 RRM domains to enhance stability and inhibit ALS/AD-associated fibrillation. Biochem. Biophys. Res. Commun. 2020 doi: 10.1016/j.bbrc.2019.11.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.11.088</ArticleId><ArticleId IdType="pubmed">31759630</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky PJ, Daujotyte D, Tollervey JR, Ule J, Stuani C, Buratti E, Baralle FE, Damberger FF, Allain FHT. Molecular basis of UG-Rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 2013;20:1443&#x2013;1449. doi: 10.1038/nsmb.2698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2698</ArticleId><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj A, Myers MP, Buratti E, Baralle FE. Characterizing TDP-43 interaction with its RNA targets. Nucleic Acids Res. 2013;41:5062&#x2013;5074. doi: 10.1093/nar/gkt189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt189</ArticleId><ArticleId IdType="pmc">PMC3643599</ArticleId><ArticleId IdType="pubmed">23519609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, Funk C, Abou-Ajram C, Hutten S, Funk EBE, Kehlenbach RH, Bailer SM, Dormann D. Nuclear egress of TDP-43 and FUS occurs independently of exportin-1/CRM1. Sci. Rep. 2018;8:1&#x2013;18. doi: 10.1038/s41598-018-25007-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25007-5</ArticleId><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinarbasi ES, Ca&#x1e7;atay T, Fung HYJ, Li YC, Chook YM, Thomas PJ. Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci. Rep. 2018 doi: 10.1038/s41598-018-25008-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25008-4</ArticleId><ArticleId IdType="pmc">PMC5935693</ArticleId><ArticleId IdType="pubmed">29728608</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini A, Chauhan VS. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment. ChemBioChem. 2011 doi: 10.1002/cbic.201100427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.201100427</ArticleId><ArticleId IdType="pubmed">21905193</ArticleId></ArticleIdList></Reference><Reference><Citation>Shodai A, Ido A, Fujiwara N, Ayaki T, Morimura T, Oono M, Uchida T, Takahashi R, Ito H, Urushitani M. Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43. PLoS ONE. 2012;7:e52776. doi: 10.1371/journal.pone.0052776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052776</ArticleId><ArticleId IdType="pmc">PMC3530536</ArticleId><ArticleId IdType="pubmed">23300771</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Raphael AR, Ladow ES, Mcgurk L, Weber RA, Trojanowski JQ, Lee VMY, Finkbeiner S, Gitler AD, Bonini NM. Therapeutic modulation of EIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014 doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xed;gh L, Liter&#xe1;ti PN, Horv&#xe1;th I, T&#xf6;r&#xf6;k Z, Balogh G, Glatz A, Kov&#xe1;cs E, Boros I, Ferdin&#xe1;ndy P, Farkas B, et al. Bimoclomol: A nontoxic, hydroxylamine derivative with stress protein- inducing activity and cytoprotective effects. Nat. Med. 1997 doi: 10.1038/nm1097-1150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1097-1150</ArticleId><ArticleId IdType="pubmed">9334730</ArticleId></ArticleIdList></Reference><Reference><Citation>Berson A, Goodman LD, Sartoris AN, Otte CG, Aykit JA, Lee VMY, Trojanowski JQ, Bonini NM. Drosophila Ref1/ALYREF regulates transcription and toxicity associated with ALS/FTD disease etiologies. Acta Neuropathol. Commun. 2019 doi: 10.1186/s40478-019-0710-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0710-x</ArticleId><ArticleId IdType="pmc">PMC6487524</ArticleId><ArticleId IdType="pubmed">31036086</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Lorenzini I, Chou CC, Torvund M, Rogers RS, Starr A, Zaepfel BL, Levy J, Johannesmeyer J, Schwartz JC, et al. Post-transcriptional inhibition of Hsc70-4/HSPA8 expression leads to synaptic vesicle cycling defects in multiple models of ALS. Cell Rep. 2017 doi: 10.1016/j.celrep.2017.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.09.028</ArticleId><ArticleId IdType="pmc">PMC5679478</ArticleId><ArticleId IdType="pubmed">28978466</ArticleId></ArticleIdList></Reference><Reference><Citation>Armakola M, Higgins MJ, Figley MD, Barmada SJ, Scarborough EA, Diaz Z, Fang X, Shorter J, Krogan NJ, Finkbeiner S, et al. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat. Genet. 2012 doi: 10.1038/ng.2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2434</ArticleId><ArticleId IdType="pmc">PMC3510335</ArticleId><ArticleId IdType="pubmed">23104007</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C, Deisel J, Aufschnaiter A, Ambros S, Tereshchenko M, Verheijen BM, B&#xfc;ttner S, Braun RJ. TDP-43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity. Hum. Mol. Genet. 2018 doi: 10.1093/hmg/ddy066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy066</ArticleId><ArticleId IdType="pubmed">29474575</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Gomes E, Guo L, Mojsilovic-Petrovic J, Tran V, Kalb RG, Shorter J, Bonini NM. Poly(ADP-Ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol. Cell. 2018;71:703&#x2013;717.e9. doi: 10.1016/j.molcel.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons M, Prieto S, Miguel L, Frebourg T, Campion D, Su&#xf1;&#xe9; C, Lecourtois M. Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila. Acta Neuropathol. Commun. 2018 doi: 10.1186/s40478-018-0639-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0639-5</ArticleId><ArticleId IdType="pmc">PMC6292132</ArticleId><ArticleId IdType="pubmed">30541625</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, Sayegh M, Donlin-Asp PG, Chen YH, Duong DM, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018 doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Berson A, Sartoris A, Nativio R, Van Deerlin V, Toledo JB, Porta S, Liu S, Chung CY, Garcia BA, Lee VMY, et al. TDP-43 promotes neurodegeneration by impairing chromatin remodeling. Curr. Biol. 2017 doi: 10.1016/j.cub.2017.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2017.10.024</ArticleId><ArticleId IdType="pmc">PMC5720388</ArticleId><ArticleId IdType="pubmed">29153328</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun FC, Wei S, Li CW, Chang YS, Chao CC, Lai YK. Localization of GRP78 to mitochondria under the unfolded protein response. Biochem. J. 2006 doi: 10.1042/BJ20051916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20051916</ArticleId><ArticleId IdType="pmc">PMC1450007</ArticleId><ArticleId IdType="pubmed">16433633</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu R, Ni M, Gill P, Lee AS. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J. Biol. Chem. 2010 doi: 10.1074/jbc.M109.087445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.087445</ArticleId><ArticleId IdType="pmc">PMC2865300</ArticleId><ArticleId IdType="pubmed">20208072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandell RB, Feldherr CM. Identification of two HSP70-related xenopus oocyte proteins that are capable of recycling across the nuclear envelope. J. Cell Biol. 1990;111:1775&#x2013;1783. doi: 10.1083/jcb.111.5.1775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.111.5.1775</ArticleId><ArticleId IdType="pmc">PMC2116324</ArticleId><ArticleId IdType="pubmed">2229173</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrara M, Prischi F, Ali MMU. UPR signal activation by luminal sensor domains. Int. J. Mol. Sci. 2013;14:6454&#x2013;6466. doi: 10.3390/ijms14036454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms14036454</ArticleId><ArticleId IdType="pmc">PMC3634511</ArticleId><ArticleId IdType="pubmed">23519110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000;2:326&#x2013;332. doi: 10.1038/35014014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35014014</ArticleId><ArticleId IdType="pubmed">10854322</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, Copley KE, Hurtle B, Portz B, Pyles NJ, et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102:321&#x2013;338.e8. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HJ, Topp SD, Hui HS, Zacco E, Katarya M, McLoughlin C, King A, Smith BN, Troakes C, Pastore A, et al. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Brain. 2019;142:3753&#x2013;3770. doi: 10.1093/brain/awz313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz313</ArticleId><ArticleId IdType="pmc">PMC6885686</ArticleId><ArticleId IdType="pubmed">31605140</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 2009;18:3353&#x2013;3364. doi: 10.1093/hmg/ddp275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp275</ArticleId><ArticleId IdType="pubmed">19515851</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, Clark CM, Elman LB, Miller BL, Grossman M, et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 2008;173:182&#x2013;194. doi: 10.2353/ajpath.2008.080003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080003</ArticleId><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Lee VMY, Trojanowski JQ. Gains or losses: Molecular Mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 2012;13:38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordana MT, Piccinini M, Grifoni S, De Marco G, Vercellino M, Magistrello M, Pellerino A, Buccinn&#xe0; B, Lupino E, Rinaudo MT. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 2010;20:351&#x2013;360. doi: 10.1111/j.1750-3639.2009.00284.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2009.00284.x</ArticleId><ArticleId IdType="pmc">PMC8094784</ArticleId><ArticleId IdType="pubmed">19338576</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, Newcombe J, Troakes C, Simone R, Chen YR, Patani R, Sidle K. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol. Dis. 2016;96:236&#x2013;247. doi: 10.1016/j.nbd.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5113659</ArticleId><ArticleId IdType="pubmed">27590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Mimura N, Kashio M, Koseki H, Aoe T. Late-onset of spinal neurodegeneration in knock-in mice expressing a mutant BIP. PLoS ONE. 2014;9:e112837. doi: 10.1371/journal.pone.0112837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0112837</ArticleId><ArticleId IdType="pmc">PMC4236098</ArticleId><ArticleId IdType="pubmed">25405877</ArticleId></ArticleIdList></Reference><Reference><Citation>Fil&#xe9;zac De L&#x2019;Etang A, Maharjan N, Cordeiro Bran&#xe3; M, Ruegsegger C, Rehmann R, Goswami A, Roos A, Troost D, Schneider BL, Weis J, et al. Marinesco-Sj&#xf6;gren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS. Nat. Neurosci. 2015;18:227&#x2013;233. doi: 10.1038/nn.3903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3903</ArticleId><ArticleId IdType="pubmed">25559081</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Rifai O, Bonini NM. TDP-43 a Protein Central to Amyotrophic Lateral Sclerosis Is Destabilized by Tankyrase-1/2. J. Cell Sci. 2020 doi: 10.1242/JCS.245811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/JCS.245811</ArticleId><ArticleId IdType="pmc">PMC7328137</ArticleId><ArticleId IdType="pubmed">32409565</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Lee J, Liem D, Ping P. HSPA5 gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum. Gene. 2017;618:14&#x2013;23. doi: 10.1016/j.gene.2017.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2017.03.005</ArticleId><ArticleId IdType="pmc">PMC5632570</ArticleId><ArticleId IdType="pubmed">28286085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Olberding KE, White C, Li C. Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis. Cell Death Differ. 2011 doi: 10.1038/cdd.2010.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2010.68</ArticleId><ArticleId IdType="pmc">PMC2947581</ArticleId><ArticleId IdType="pubmed">20539308</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins F, Sousa J, Pereira CD, da Cruz e Silva OAB, Rebelo S. Nuclear envelope dysfunction and its contribution to the aging process. Aging Cell. 2020;19:e13143. doi: 10.1111/acel.13143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13143</ArticleId><ArticleId IdType="pmc">PMC7253059</ArticleId><ArticleId IdType="pubmed">32291910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S, Dormann D. Nucleocytoplasmic transport defects in neurodegeneration: Cause or consequence? Semin. Cell Dev. Biol. 2020;99:151&#x2013;162. doi: 10.1016/j.semcdb.2019.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.020</ArticleId><ArticleId IdType="pubmed">31152789</ArticleId></ArticleIdList></Reference><Reference><Citation>Li WW, Sistonen L, Morimoto RI, Lee AS. Stress induction of the mammalian GRP78/BiP protein gene. In vivo genomic footprinting and identification of P70CORE from human nuclear extract as a DNA-binding component specific to the stress regulatory element. Mol. Cell. Biol. 1994;14:5533&#x2013;5546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC359073</ArticleId><ArticleId IdType="pubmed">8035828</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan DR, Xiao X, Shao L, Graves K, Benjamin IJ. Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J. Biol. Chem. 1998;273:7523&#x2013;7528. doi: 10.1074/jbc.273.13.7523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.13.7523</ArticleId><ArticleId IdType="pubmed">9516453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong M, Lin MY, Huang JM, Baumeister P, Hakre S, Roy AL, Lee AS. Transcriptional regulation of the Grp78 promoter by endoplasmic reticulum stress: Role of TFII-I and its tyrosine phosphorylation. J. Biol. Chem. 2005;280:16821&#x2013;16828. doi: 10.1074/jbc.M413753200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M413753200</ArticleId><ArticleId IdType="pubmed">15664986</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois-Moutal L, Felemban R, Scott DD, Sayegh MR, Miranda VG, Perez-Miller S, Khanna R, Gokhale V, Zarnescu DC, Khanna M. Small molecule targeting TDP-43&#x2019;s RNA recognition motifs reduces locomotor defects in a Drosophila model of amyotrophic lateral sclerosis (ALS) ACS Chem. Biol. 2019;14:2006&#x2013;2013. doi: 10.1021/acschembio.9b00481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.9b00481</ArticleId><ArticleId IdType="pmc">PMC6911355</ArticleId><ArticleId IdType="pubmed">31241884</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollasalehi N, Francois-Moutal L, Scott DD, Tello JA, Williams H, Mahoney B, Carlson JM, Dong Y, Li X, Miranda VG, et al. An allosteric modulator of RNA binding targeting the N-terminal domain of TDP-43 yields neuroprotective properties. ACS Chem. Biol. 2020 doi: 10.1021/acschembio.0c00494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.0c00494</ArticleId><ArticleId IdType="pmc">PMC8548910</ArticleId><ArticleId IdType="pubmed">33044808</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Rifai OM, Shcherbakova O, Perlegos AE, Byrns CN, Carranza FR, Zhou HW, Kim H-J, Zhu Y, Bonini NM. Toxicity of pathogenic Ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence. Hum. Mol. Genet. 2021;30:1797&#x2013;1810. doi: 10.1093/hmg/ddab148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab148</ArticleId><ArticleId IdType="pmc">PMC8444453</ArticleId><ArticleId IdType="pubmed">34077532</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW. Image J2: ImageJ for the next generation of scientific image data. BMC Bioinform. 2017 doi: 10.1186/s12859-017-1934-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-017-1934-z</ArticleId><ArticleId IdType="pmc">PMC5708080</ArticleId><ArticleId IdType="pubmed">29187165</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>